Position in ABBV
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$22,369,537
-$810,328 QoQ
Shares Held
88,895
-16.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.65%
of 13F equity value
Holder Rank
#574
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 38%
Shared 0%
None 62%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NEVILLE RODIE & SHAW INC holds $104,588,687 across 10 Drug Manufacturers - General names. ABBV ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
168,188 | $42,714,706 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
88,895 | $22,369,537 | |
| 3 | LLY |
ELI LILLY & Co
|
17,226 | $20,661,382 | |
| 4 | MRK |
Merck & Co., Inc.
|
87,699 | $11,269,321 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
39,489 | $2,275,356 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
14,844 | $1,875,390 | |
| 7 | PFE |
Pfizer Inc
|
64,658 | $1,556,964 | |
| 8 | NVS |
Novartis AG
|
5,610 | $879,199 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,369,537 | 88,895 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $23,179,865 | 106,579 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $23,308,035 | 102,009 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $19,450,517 | 84,005 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $15,625,491 | 84,180 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $19,174,222 | 91,515 | Shares | Sole | 2025-04-01 | |
| 2024-12-31 | $17,171,150 | 96,630 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $19,928,694 | 100,915 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $16,421,839 | 95,743 | Shares | Sole | 2024-07-01 | |
| 2024-03-31 | $17,296,040 | 94,981 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $14,918,806 | 96,269 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $14,595,955 | 97,920 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $13,462,221 | 99,920 | Shares | Sole | 2023-07-06 | |
| 2023-03-31 | $19,401,703 | 121,740 | Shares | Sole | 2023-04-04 | |
| 2022-12-31 | $19,819,042 | 122,635 | Shares | Sole | 2023-01-03 | |
| 2022-09-30 | $16,522,727 | 123,111 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $18,934,863 | 123,628 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $20,379,496 | 125,714 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $17,047,807 | 125,907 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $13,688,378 | 126,897 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $14,347,181 | 127,372 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $13,826,619 | 127,764 | Shares | Sole | 2021-04-08 | |
| 2020-12-31 | $13,949,643 | 130,188 | Shares | Sole | 2021-03-04 | |
| 2020-09-30 | $11,907,509 | 135,946 | Shares | Sole | 2020-10-01 | |
| 2020-06-30 | $12,530,319 | 127,626 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $7,414,734 | 97,319 | Shares | Sole | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||